CybeRelease: (OTC: FRLE) to Deliver the First Boats to Its Dealership Network
(CybeRelease, May 30, 2007) - Lake Harmony, Pa. - Fearless International Inc. (OTC BB: FRLE), a luxury performance boat manufacturer with an exclusive collaboration with internationally renowned Porsche Design Studio, announces today that the Company will begin delivering the first production boats to its dealership network next week.
The Fearless 28 first debuted at the Miami Boat Show in February 2007. Since its debut, the 28 have received tremendous interest and press coverage, including features in Maxim Magazine and the June issue of GQ Magazine. Selected dealers will begin receiving their predetermined allotment of the Fearless 28 beginning next week.
Jeffrey Binder, CEO of Fearless International Inc., said, ``To have the first boats coming off of the production line is a great accomplishment for our company. Interest in the boat has far surpassed its availability. The 28’s customized elegance combined with state-of-the-art materials and construction methods has created a new standard of excellence in the luxury speedboat segment.’’
Fearless Yachts is the forerunner in sleek design and custom luxury in the performance boat and go-fast yacht industries. For more information please visit http://www.fearlessyachts.com and http://www.fearlessinternational.com.
To read the complete release, go to http://biz.yahoo.com/pz/070529/120445.html
For an updated and in-depth profile, please visit
CybeRelease Gainers are Leading Brands Inc. (Nasdaq: LBIX), Silicom Ltd. (Nasdaq: SILC), InfoSpace, Inc. (Nasdaq: INSP), MIVA, Inc. (Nasdaq: MIVA), Global Sources Ltd. (Nasdaq: GSOL), Nashua Corporation (Nasdaq: NSHA), SMTC Corporation (Nasdaq: SMTX) and Medis Technologies Ltd. (Nasdaq: MDTL).
CybeRelease Decliners are Cypress Bioscience, Inc. (Nasdaq: CYPB), Jones Soda Co. (Nasdaq: JSDA), CytRx Corporation (Nasdaq: CYTR), Iomai Corporation (Nasdaq: IOMI), Imax Corporation (Nasdaq: IMAX), Coast Financial Holdings, Inc. (Nasdaq: CFHI), On Track Innovations Ltd (Nasdaq: OTIV) and CollaGenex Pharmaceuticals, Inc. (Nasdaq: CGPI).
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.
- Contact Information
- C. P. Barry
- Media Contact
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.